Results 131 to 140 of about 2,050,369 (162)
Some of the next articles are maybe not open access.
Seminars in hematology, 1999
Adoptive immunotherapy, or the transfer of immunocompetent cells, has been shown to be a promising new strategy for treatment of a variety of malignancies, including leukemia and non-Hodgkin's lymphoma. The possibility that it may likewise benefit patients with multiple myeloma is now being explored by researchers in Europe and the United States.
Lokhorst, H.M., Liebowitz, D.
openaire +2 more sources
Adoptive immunotherapy, or the transfer of immunocompetent cells, has been shown to be a promising new strategy for treatment of a variety of malignancies, including leukemia and non-Hodgkin's lymphoma. The possibility that it may likewise benefit patients with multiple myeloma is now being explored by researchers in Europe and the United States.
Lokhorst, H.M., Liebowitz, D.
openaire +2 more sources
The rapidly changing landscape in mature T‐cell lymphoma (MTCL) biology and management
Ca-A Cancer Journal for Clinicians, 2020Enrica Marchi
exaly
A review of cancer immunotherapy toxicity
Ca-A Cancer Journal for Clinicians, 2020Lucy Boyce Kennedy
exaly
Photodynamic therapy of cancer: An update
Ca-A Cancer Journal for Clinicians, 2011Patrizia M Agostinis +2 more
exaly